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Abstract
This study was undertaken to investigate the effects of dietary lysine on the plasma con-
centrations of three growth‐related hormones in pigs. Nine late‐stage finishing barrows 
were assigned to three dietary treatments according to a completely randomized experi-
mental design (3 pigs/treatment). Three corn and soybean meal‐based diets were formu-
lated to contain three levels of lysine, which were 0.43, 0.71, and 0.98% for Diets 1 (lysine 
deficient), 2 (lysine adequate), and 3 (lysine excess), respectively. The feeding trial lasted 4 
weeks, during which the pigs were allowed ad libitum access to the diets and water. After 
the 4 weeks, blood was collected and plasma samples were obtained. Then, the plasma 
concentrations of insulin, growth hormone (GH), and insulin‐like growth factor 1 (IGF‐1) 
were measured. No difference in the plasma concentration of insulin or GH among the 
three treatments was found (P > 0.10). However, the plasma IGF‐1 concentration was lower 
(P < 0.05) in the pigs fed Diet 1 or 3 than fed Diet 2, suggesting that either dietary lysine 
deficiency or excess can lead to a lower concentration of plasma IGF‐1. It was concluded 
that IGF‐1, instead of insulin or GH, in the blood may be a key controlling growth factor in 
response to dietary lysine supply for regulating muscle growth in late‐stage finishing pigs.
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1. Introduction
The biochemical process of protein turnover in the skeletal muscle of pigs is of great impor-
tance for the production of food protein for human consumption [1]. Some nutrients, such as 
glucose and fatty acids, play important roles not only as energetic substrates but also as cell 
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
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signaling molecules to regulate the protein turnover in animal body [2–4]. Similarly, besides 
their function as building blocks for body protein biosynthesis, some amino acids (AAs) can 
also function as cell signaling molecules regulating those metabolic pathways that are neces-
sary for muscle protein accretion [5, 6]. The regulation of key signaling and metabolic path-
ways of muscle protein turnover by AAs (Wang et al., personal communication) is closely 
associated with the concomitant responses of some growth‐related hormones [1, 7, 8].
The plasma concentrations of growth‐related polypeptide hormones, such as insulin, growth 
hormone (GH; a.k.a. somatotropin), and insulin‐like growth factor 1 (IGF‐1), can be affected 
by animal nutritional status and, in turn, regulate cell and tissue growth and development in 
animal body [9–11]. Because these hormones are not fat‐soluble, they cannot penetrate cell 
membranes into cytosol. Therefore, they exert cell signaling effects through binding to their 
corresponding receptors on the cell membranes, where they further activate cell signaling 
cascades to regulate gene expression and protein turnover [7, 12].
Lysine is the first limiting AA in typical grain‐based swine diets [1, 13], and sufficient dietary 
lysine supply is critical for pig growth performance, especially the growth of skeletal muscle, 
the largest AA reservoir in the body [14–16]. According to some previous studies on growing 
pigs [14, 17], dietary lysine supplementation stimulated the insulin secretion, increased the 
plasma insulin concentration, but not the plasma concentrations of GH and IGF‐1, in a dose‐
dependent manner. On nursery pigs, it was reported that the plasma IGF‐1 concentration was 
reduced when animals were fed a diet lower in lysine level [18]. However, whether or not 
the effect of dietary lysine on the growth performance of finishing pigs is mediated via these 
growth‐related hormones is still unknown. Therefore, the objective of this study was to inves-
tigate the effect of dietary lysine at different levels on the plasma concentrations of three key 
growth‐related hormones, which were insulin, GH, and IGF‐1, in late‐stage finishing pigs.
2. Materials and methods
2.1. Animal trial and sample collection
All the experimental protocols involving caring, handling, and treatment of pigs were 
approved by Mississippi State University Institutional Animal Care and Use Committee. 
A total of nine crossbred (Large White × Landrace) barrows with an average initial body 
weight (BW) 94.4 ± 6.7 kg were housed in an environment‐controlled swine barn at the Leveck 
Animal Research Center of Mississippi State University. The pigs were randomly assigned 
to nine individual feeding pens, and then were assigned to three dietary treatment groups 
according to a completely randomized experimental design. Each treatment consisted of 3 
pen replicates (n = 3) with one pig per pen.
A corn and soybean meal‐based diet (a lysine‐deficient diet; defined as Diet 1) was formulated 
to meet or exceed the NRC [13] recommended requirements of various nutrients, including 
crude protein (CP) and essential AAs, but not of lysine. Diet 2 (a lysine‐adequate diet) and 
Diet 3 (a lysine‐excess diet) were formulated by adding L‐lysine monohydrochloride (Archer 
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Daniels Midland Co., Quincy, IL, USA) to Diet 1 at the expense of corn at the rates of 0.35% and 
0.70%, respectively (Table 1). The total lysine contents (calculated, as‐fed basis) in Diets 1, 2, and 
3 were 0.43, 0.71, and 0.98%, respectively. To confirm the contents of major nutrients, samples 
of the three diets were submitted to the Essig Animal Nutrition Laboratory at Mississippi State 
University for proximate analysis, and the results are shown in Table 2. The AA contents of the 
three diets were analyzed by using the high‐performance liquid chromatography methods [19] 
at Texas A&M University (College Station, TX, USA), and the results are also shown in Table 2.
Diet 1 Diet 2 Diet 3
Ingredients (%)
Corn 90.844 90.494 90.144
Soybean meal 6.400 6.400 6.400
Canola oil 0.800 0.800 0.800
L‐Lysine‐HCl (98.5%) 0.000 0.350 0.700
DL‐Methionine (99%) 0.040 0.040 0.040
L‐Threonine (98.5%) 0.090 0.090 0.090
L‐Tryptophan (99%) 0.035 0.035 0.035
Limestone 0.650 0.650 0.650
Dicalcium phosphate 0.900 0.900 0.900
Salt 0.200 0.200 0.200
Mineral premix2 0.033 0.033 0.033
Vitamin premix3 0.008 0.008 0.008





Crude Protein (%) 10.45 10.75 11.05
Total Lysine (%) 0.43 0.71 0.98
Total Methionine (%) 0.24 0.24 0.24
Total Threonine (%) 0.50 0.50 0.50
Total Tryptophan (%) 0.14 0.14 0.14
Total Ca (%) 0.46 0.46 0.46
Total P (%) 0.43 0.43 0.43
1Diets 1, 2, and 3 were formulated to contain dietary lysine at 0.43%, 0.71%, and 0.98% (as‐fed basis), respectively, of 
which Diets 2 and 3 were formulated by adding 0.35% and 0.70% L‐lysine‐HCl (Archer Daniels Midland Co., Quincy, 
IL) to Diet 1 at the expense of corn.
2The mineral premix contained 13.2% Ca, 1.0% Cu, 8.0% Fe, 5.0% Mn, 10.0% Zn, 500 ppm I, and 300 ppm Se.
3Each kilogram of vitamin premix contained the following: 22.05 million IU vitamin A, 3.31 million IU vitamin D3, 66,138 
IU vitamin E, 88 mg vitamin B12, 220 mg biotin, 8,818 mg menadione, 15,432 mg riboflavin, 61,728 mg d‐pantothenic 
acid, and 88,183 mg niacin.
4Calculated major nutrients.
Table 1. Ingredient and nutrient compositions (as‐fed basis) of the three experimental diets fed to the late‐stage finishing 
pigs1.
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Nutrient and Energy Experimental Diet
Diet 1 Diet 2 Diet 3
Dry matter, % 87.10 87.10 87.10
Gross energy, kcal/kg 3,663 3,608 3,559
Crude protein, % 9.77 10.60 10.86
Individual Amino Acids, %
Lysine 0.42 0.70 1.01
Aspartate 0.98 0.97 0.98
Asparagine 0.74 0.75 0.75
Glutamate 1.01 1.03 1.03
Glutamine 1.42 1.44 1.43
Serine 0.53 0.52 0.54
Histidine 0.34 0.33 0.34
Glycine 0.61 0.62 0.62
Threonine 0.50 0.51 0.50
Arginine 0.73 0.74 0.74
Alanine 0.81 0.83 0.82
Tyrosine 0.52 0.52 0.53
Tryptophan 0.14 0.13 0.14
Methionine 0.25 0.25 0.26
Valine 0.65 0.66 0.65
Phenylalanine 0.66 0.65 0.66
Isoleucine 0.52 0.52 0.53
Leucine 1.42 1.44 1.45
Cysteine 0.26 0.26 0.30
Proline 1.08 1.07 1.09
1The energy, crude protein, and dry matter contents were analyzed at the Essig Animal Nutrition Laboratory, Mississippi 
State University (Starkville, MS, USA). The amino acid contents were analyzed at Texas A&M University (College 
Station, TX, USA).
Table 2. The analyzed nutrient compositions (as‐fed basis) of three experimental diets fed to the late‐stage finishing 
pigs1.
The feeding trial lasted a total of 4 weeks, during which the pigs were allowed ad libitum access 
to the experimental diets and fresh water. All the pigs, feeders, waterers, and room tempera-
ture were checked two to three times on a daily basis (6:00 am to 7:00 pm). After the 4‐week 
trial period, blood samples were collected by venipuncture of the jugular veins of individual 
pigs (10 mL/pig) in the early morning (6:00–8:00 am). Immediately after collection, the blood 
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samples were kept onto ice until the plasma was separated by centrifugation (at 800 × g) of the 
vacutainer tubes at 4°C for 16 min. The plasma samples were then stored in 200 μL aliquots at 
−80°C until the laboratory analysis of hormones was conducted.
2.2. Laboratory analyses of the growth‐related hormones
2.2.1. Analysis of plasma insulin
The plasma concentration of insulin was measured in duplicate using a porcine insulin ELISA 
kit (ENZO Life Sciences, Farmingdale, NY, USA) according to the manufacturer’s instructions. 
Briefly, the plasma samples were first diluted (1:3) to remove matrix interference. The diluted 
samples were then added to a pre‐coated insulin ELISA plate (100 μL/well/sample) and incu-
bated on an orbital shaker (Forma 420; Thermo Fisher Scientific Inc., USA) at room tempera-
ture for 1 h, allowing the liquid to be thoroughly mixed. The plate was then rinsed four times 
with wash buffer (200 μL/well) and blotted on lint free paper towels after each rinse. After the 
final blot, the primary insulin antibody solution was added to the plate (100 μL/well) and incu-
bated on the shaker at room temperature for 1 h. Residual primary antibody on the plate was 
then rinsed and blotted as described above. One hundred microliter of blue solution of horse-
radish peroxidase (HRP) conjugate was added to each well, and the plate was incubated on 
the shaker at room temperature for 30 min. After incubation, the plate was rinsed and blotted 
again to remove the residual blue conjugate if any. Then the HRP substrate solution was added 
to the plate (100 μL/well) and the plate was incubated on the shaker at room temperature for 
30 min again. Finally, the reaction stop solution was added to the plate (100 μL/well), and the 
optical density (OD) value of the solution was measured at 450 nm using a microplater reader 
(SpectraMax Plus 384; Molecular Devices, San Francisco, CA, USA). The insulin concentration 
of each sample was calculated based on the OD values of the standard curve of known concen-
trations using Curve Expert 1.4 computer program (http://www.curveexpert.net).
2.2.2. Analysis of plasma growth hormone
The plasma concentration of GH was measured in duplicate using a porcine GH ELISA kit 
(Cloud‐Clone Corp., Wuhan, China) according to the manufacturer’s instructions. Briefly, 
the plasma samples were added to a pre‐coated GH ELISA plate (100 μL/well/sample) and 
incubated at 37°C for 2 h. Then, the liquid was removed from each well, the “Detection 
Reagent A” working solution was added to each well (100 μL/well), and the plate was incu-
bated at 37°C for 1 h. The plate was then rinsed three times with wash buffer (350 μL/well) 
and blotted on lint free paper towels after each rinse. Following the final blot, the “Detection 
Reagent B” working solution was added to the plate (100 μL/well), which was incubated at 
37°C for 30 min. The plate was rinsed and blotted again for five times as described above. The 
substrate solution was then added to the plate (90 μL/well), and the plate was incubated at 
37°C for 15 min with protection from light. Finally, the reaction stop solution was added to 
the plate (50 μL/well), and the OD value of the solution in each well was measured at 450 nm 
using a microplater reader (SpectraMax Plus 384). The GH concentration of each sample was 
calculated based on its OD values against the standard curve of known concentrations using 
Curve Expert 1.4 computer program (http://www.curveexpert.net).
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2.2.3. Analysis of plasma insulin‐like growth factor 1
The plasma concentration of IGF‐1 was measured in duplicate using a human IGF‐1 ELISA kit 
(ENZO Life Sciences) according to the manufacturer’s instructions. Briefly, each plasma sam-
ple was mixed in a solution of 100% ethanol (1:5) and 2 N hydrochloric acid (7:1) and incubated 
at room temperature for 30 min to dissociate IGF‐1 from IGF binding proteins. The binding 
proteins were then pelleted by centrifugation at 9900 × g for 5 min at room temperature. The 
supernatant was removed and neutralized with an equal volume of the neutralizing reagent. 
The supernatant sample was then diluted to a final concentration of 1:35 with the assay buffer.
The diluted samples in the assay buffer were added to a pre‐coated IGF‐1 ELISA plate (100 μL/
well/sample) and incubated on the orbital shaker (Forma 420, Thermo Fisher Scientific Inc.) at 
room temperature for 1 h, allowing the liquid to be thoroughly mixed. The ELISA plate was 
rinsed five times with the wash buffer (200 μL/well) and blotted on lint free paper towels after 
each rinse. After the final blot, the primary IGF‐1 antibody solution was added to the plate 
(100 μL/well) and the plate was incubated on the shaker at room temperature for 2 h. Residual 
primary antibody on the plate was then rinsed and blotted again as described earlier. Then, 
the blue solution of HRP conjugate was added to the plate (100 μL/well) and the plate was 
incubated on the shaker again at room temperature for 30 min. After incubation, the plate was 
rinsed and blotted to remove any residual blue conjugate. The HRP substrate solution was 
then added to the plate (100 μL/well), which was incubated on the shaker at room tempera-
ture for 30 min. Finally, the reaction stop solution was added to the plate (100 μL/well), and 
the OD value of the solution in each well was measured at 450 nm using a microplater reader 
(SpectraMax Plus 384). The plasma IGF‐1 concentration of each sample was calculated based 
on OD values against the standard curve of known concentrations using Curve Expert 1.4 
computer program (http://www.curveexpert.net).
2.3. Statistical analysis
The plasma concentration of each hormone of each sample was averaged from 2 values of the 
duplicate measurements and then subjected to analysis of variance (ANOVA) for a completely 
randomized experimental design using the general linear model (GLM) procedure of SAS 9.4 
(SAS Institute Inc., Cary, NC, USA) with dietary lysine level being the main effect and indi-
vidual pigs being the experiment units. Three means of the treatments were separated by the 
protected t‐test using the LSMEANS/PDIFF option in the GLM procedure. Probability values 
(P) less than 0.05 were considered as significant differences and the P values between 0.05 and 
0.10 were considered as tendencies to be different.
3. Results and discussions
3.1. Lysine effect on the plasma insulin concentration
As shown in Figure 1A, there are no differences in the plasma insulin concentrations 
(P = 0.25) among the three dietary treatments, which suggests that the plasma insulin 
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level of the late‐stage finishing pigs was not affected by the dietary lysine concentration, 
at least at the range from 0.43 to 0.98% (Table 1). As it is known, insulin plays a critical 
role in the metabolism of nutrients such as carbohydrates, lipids and proteins, and is a 
primary acute anabolic coordinator of nutrient partitioning [20]. As a signaling molecule, 
insulin can activate the insulin signaling transduction pathway, leading to an increase in 
phosphatidylinositol 3‐kinase (PI3K) activity followed by an increase in protein kinase B 
Figure 1. ELISA analyses of the plasma concentrations of (A) insulin, (B) growth hormone (GH), and (C) insulin‐like 
growth factor 1 (IGF‐1) in the late‐stage finishing pigs fed a lysine‐deficient diet (Diet 1), a lysine‐adequate diet (Diet 2), or 
a lysine‐excess diet (Diet 3). Shown on the y‐axis are the hormone concentrations (μIU/mL or ng/mL) Bars denote means 
±SD. All measurements were carried out in duplicate The *signs denote differential concentrations between two treatment 
groups (P < 0.05).
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(PKB/Akt) activity. The PKB/Akt activity is associated with the phosphorylation and inhi-
bition of the tuberous sclerosis complex (TSC2) and further the mTOR (mechanistic target 
of rapamycin) kinase activity to regulate protein turnover in skeletal muscle and other 
 tissues [21, 22].
Amino acids and insulin can independently stimulate protein synthesis in skeletal muscle 
[23, 24]. However, dietary AAs or protein can also affect insulin secretion, although insulin 
is secreted primarily in response to the elevated blood glucose concentration [20, 25]. The 
reduction in dietary CP concentration has been shown to decrease plasma insulin concentra-
tion in growing pigs [10, 26]. In addition, it was observed that a leucine‐induced stimulation 
of protein synthesis in the skeletal muscle of rats was facilitated by a transient increase in the 
blood concentration of insulin [27, 28].
Different AAs may have different capacities in stimulating insulin secretion. An intrave-
nous administration of 30 g of AA mixtures or of certain individual AAs to healthy human 
subjects (19–27 years old) induced prompt and large increases in the level of plasma insulin 
[25]. While a mixture of 10 essential AAs, or the cationic lysine or arginine alone, appeared 
to be the most potent, cationic histidine was the least potent, and no obvious common phys-
icochemical property or configuration could characterize the more potent or less potent 
AAs [25]. In pigs, it was reported that dietary administration of lysine also had a stimulat-
ing effect on insulin secretion, and this stimulation is in a dose‐dependent manner. For 
example, the growing barrows fed diets containing 0.45 and 0.75% total lysine showed 
no difference in plasma insulin concentration, but the plasma insulin concentration was 
increased by 39% when dietary lysine concentration was raised to 0.98% [14]. Similarly, 
while the dietary concentration of total lysine at 0.71, 0.95, or 1.20% did not show any 
influence on plasma insulin concentration in growing pigs, 1.45% lysine in the diet sig-
nificantly increased the plasma concentration of insulin [17]. In this present study on the 
late‐stage finishing pigs, dietary lysine did not show any effect on the plasma insulin level, 
and there might be a few reasons responsible for the discrepancy between our results and 
those reported in the literature: (1) the late‐stage finishing pigs may not be as sensitive as 
young humans or young growing pigs in response to AA stimulation, (2) our dietary lysine 
concentrations (Table 1) might not be high enough to stimulate the release of insulin, and 
(3) the different blood sample collection time relative to the time of AA administration or 
feed intake might cause the differences.
3.2. Lysine effects on the plasma concentrations of growth hormone and insulin‐like 
growth factor 1
As shown in Figure 1B, there are no differences in the plasma GH concentrations (P = 0.18) 
among the three dietary treatments, which suggests that the plasma GH level of the late‐stage 
finishing pigs was not affected by the dietary lysine concentration, at least at the range from 
0.43 to 0.98% (Table 1). As shown in Figure 1C, however, the plasma IGF‐1 concentration of 
the pigs fed either Diet 1 or Diet 3 was lower (P < 0.05) than that of the pigs fed Diet 2, which 
suggests that either dietary lysine deficiency or dietary lysine excess can lead to a lower level 
of plasma IGF‐1 concentration in the late‐stage finishing pigs.
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In humans, it has been shown that the plasma level of GH can change in response to a number 
of physiologic stimuli, including plasma AAs [29]. Different single AAs intravenously admin-
istrated into blood vary in their capacities to evoke a release of GH into the blood circulation 
[29]. Oral administration of lysine (1200 mg) plus arginine (1200 mg) to some healthy volun-
teers (male, aged 15–20 years) also provoked a release of GH and insulin into the blood, and 
this effect appeared to be specific to the combination of these two AAs because neither one 
demonstrated appreciable stimulating activity when administered alone [30].
Primarily consisting of GH, IGF‐1, and their associated carrier proteins and receptors, somato-
tropin axis (a.k.a., GH‐IGF‐1 axis) is a very critical regulatory pathway for mammalian muscle 
growth and development, as well as the protein and lipid metabolism in various tissues [31–33]. 
The stimulating effect of GH on the growth and development of pig muscle has been reported 
by many previous in vivo studies with daily injection (i.m.) of exogenous porcine GH [34, 35], 
and it was hypothesized that the actions of GH on muscle growth are mediated by the insulin‐
like growth factors (IGFs). A great deal of evidence supports the view that the IGFs (especially, 
IGF‐1) are important myogenic agents that could mediate the actions of GH, but this did not 
demonstrate that GH has no direct effect on the skeletal muscle to stimulate its growth [32].
Essential AAs, especially lysine, can promote swine muscle growth when sufficiently supplied, 
but it is unknown how or if its promotion effect on swine muscle growth is mediated via the 
GH‐IGF‐1 axis. This present study showed that the plasma concentration of IGF‐1 in the late‐
stage finishing pigs fed either a lysine‐deficient or lysine‐excess diet was reduced (P < 0.05), 
although the plasma concentration of GH was not affected. These results support some previ-
ous studies conducted by Roy et al. [14] and Ren et al. [17], who reported that the dietary lysine 
level had no effect on the plasma GH concentration in growing pigs.
That the dietary lysine deficiency decreased the plasma IGF‐1 concentration in the finishing 
pigs of this study supports the research conducted by Takenaka et al. [36] and Katsumata et al. 
[18], who showed that the plasma IGF‐1 concentration was reduced when young rats (6 weeks 
of age) and nursery pigs were fed the diets lower in lysine. The previous studies on growing 
pigs, however, did not show that dietary lysine levels influence the plasma concentration of 
IGF‐1 [14, 17].
The conflicting results regarding the effects of dietary lysine levels on the plasma IGF‐1 con-
centration from different studies may be due to various factors, such as animal species used, 
growing stages of the animals, and the amounts of lysine provided in the diets. It has been 
known that a principal hormonal stimulus for IGF‐1 production is GH [37]. However, it is 
interesting to find that the plasma IGF‐1 concentration of the late‐stage finishing pigs fed 
either a lysine‐deficient or a lysine‐excess diet was reduced when compared to the pigs fed 
a lysine‐adequate diet, whereas the dietary lysine level had no effect on the plasma GH con-
centration. While the animal nutritional status is a key factor in regulating the activity and 
function of GH‐IGF‐1 axis [38], the regulation of IGF‐1 release may be a key control point for 
animal muscle growth and nitrogen retention [9, 17]. In terms of animal growth performance, 
we have reported that there was no further improvement in the average daily gain when 
excess dietary lysine was provided to the late‐stage finishing pigs [16]. Therefore, the lysine 
promotion effect on pig average daily gain might not be associated with the plasma GH, and 
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the plasma IGF‐1 may be one of the limiting growth factors that restricts the pigs from further 
increasing in average daily gain or further increasing in muscle protein accretion in response 
to the dietary lysine provision above the NRC [13] recommended requirement.
4. Conclusions
The results generated from this study in late‐stage finishing pigs suggest that dietary defi-
ciency or excess of lysine did not affect the plasma concentrations of insulin and GH. However, 
the plasma concentration of IGF‐1 was affected by the dietary lysine levels. In particular, 
either dietary lysine deficiency or excess led to a reduction in the plasma concentration of 
IGF‐1 in the pigs relative to the pigs fed a lysine‐adequate diet. Thus, it can be concluded 
that IGF‐1, instead of insulin or GH, in the blood circulation may be a key controlling growth 
factor in response to dietary provision of lysine for regulating muscle growth in late‐stage 
finishing pigs.
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